Gossamer Bio, Inc. (GOSS) Operating Income (Loss) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Gossamer Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Gossamer Bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$42 M, a 12.5% increase year-over-year.
  • Gossamer Bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$178 M, a 16.2% increase year-over-year.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2023 was -$184 M, a 15.9% increase from 2022.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2022 was -$219 M, a 1.14% decline from 2021.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2021 was -$216 M, a 7.62% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$178 M -$42 M +$5.98 M +12.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$184 M -$49 M +$5.33 M +9.81% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$189 M -$40.5 M +$15.5 M +27.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$205 M -$46.3 M +$7.57 M +14.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$212 M -$47.9 M +$6.4 M +11.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$219 M -$54.4 M -$2.7 M -5.22% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$216 M -$56 M -$357 K -0.64% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$216 M -$53.9 M +$1.72 M +3.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$217 M -$54.3 M -$1.14 M -2.14% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$216 M -$51.7 M +$8.43 M +14% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$225 M -$55.7 M -$2.1 M -3.91% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$222 M -$55.6 M +$9.74 M +14.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$232 M -$53.2 M +$1.76 M +3.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$234 M -$60.1 M -$4.3 M -7.71% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 -$230 M -$53.6 M -$3.58 M -7.17% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$226 M -$65.3 M -$19 M -41% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$207 M -$55 M -$21 M -61.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$186 M -$55.8 M -$16 M -40.1% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-24
Q3 2019 -$170 M -$50 M +$38 K +0.08% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$170 M -$46.3 M -$13.3 M -40.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$157 M -$34 M -$7.89 M -30.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$149 M -$39.8 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$50 M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-24
Q2 2018 -$33 M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-24
Q1 2018 -$26.1 M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.